ArticleCancers2023

Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Giovanna Casili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.